ARMATA PHARMACEUTICALS INC
NYSE: ARMP (Armata Pharmaceuticals, Inc.)
最近更新时间: 2小时之前12.88
1.19 (10.18%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Armata Pharmaceuticals, Inc. | - | - |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.75 |
|
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 69.55% |
| 机构持股比例 | 2.13% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Seacrest Wealth Management, Llc | 31 Dec 2025 | 40,988 |
| Grey Ledge Advisors, Llc | 31 Dec 2025 | 30,000 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合